Skip Navigation Links.
American Journal of Clinical Medicine Research. 2015, 3(1), 9-13
DOI: 10.12691/AJCMR-3-1-2
Original Research

Review of the Clinical Presentation of Uterine Fibroid and the Effect of Therapeutic Intervention on Fertility

Atombosoba. A. Ekine1, Lucky O. Lawani2, , Chukwuemeka A. Iyoke3, Israel Jeremiah1 and Isa. A. Ibrahim1

1Department of Obstetrics & Gynecology, Niger Delta University Teaching Hospital, Okolobiri, Bayelsa State, Nigeria

2School of Post Graduate Studies, Department of Community Medicine, University of Nigeria, Enugu, Enugu State, Nigeria

3Department of Obstetrics & Gynecology, University of Nigeria Teaching Hospital, Enugu, Enugu State, Nigeria

Pub. Date: March 10, 2015
Full Text PDF

Cite this paper

Atombosoba. A. Ekine, Lucky O. Lawani, Chukwuemeka A. Iyoke, Israel Jeremiah and Isa. A. Ibrahim. Review of the Clinical Presentation of Uterine Fibroid and the Effect of Therapeutic Intervention on Fertility. American Journal of Clinical Medicine Research. 2015; 3(1):9-13. doi: 10.12691/AJCMR-3-1-2

Abstract

Uterine fibroid is a common gynecological problem among women of reproductive age. The objective of this study was to review the common clinical presentation of uterine fibroid and assess the effect of therapeutic intervention on fertility. A retrospective descriptive study of 368 women, who were managed for uterine fibroid over a 5 years period (January 1st, 2008 to December 311st, 2012) was conducted at a University Teaching Hospital. The main outcome measures were common presentations, effect of treatment on fertility. Data were analyzed with Epi Info™ statistical software version 7.0. The incidence of uterine fibroids was 29.3%. Fibroids mainly affected those in the reproductive age group (31-40 years). The common clinical presentations- were abdominopelvic mass (100%), menorrhagia (95.7%), infertility (41.9%), anemia (32.9%), dysmenorrhoea (12.5%), abdominopelvic pain (15.8%), and urinary pressure symptoms (6.8%). Abdominal myomectomy (97.3%) was the main stay of treatment. The Odd Ratio of achieving pregnancy within two year of therapeutic intervention was 1.33 (0.27-6.60), p-value=0.0007, while the risk ratio of recurrent pregnancy loss was about three times less in those who had therapeutic interventions [3.56 (0.52-24.21)], p-value=0.11. Uterine fibroid presents with abnormal uterine bleeding and impaired fertility in women of reproductive age, and removal conferred fertility benefits in some cases.

Keywords

uterine fibroid, pregnancy, menorrhagia, clinical presentation, fertility, myomectomy

Copyright

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]  Ezeama C, Ikechebelu J, Obiechina N, Ezeama N: Clinical Presentation of Uterine Fibroids in Nnewi, Nigeria: A 5-year Review. Ann Med Health Sci Res 2012, 2: 114-118.
 
[2]  Okeke TC, Okezie OA, Obioha KC, Ikeako LC, Ezenyeaku CC: Trends of myomectomy at the University of Nigeria Teaching Hospital (UNTH) Enugu Nigeria. Niger J Med 2011, 20: 224-227.
 
[3]  Okogbo FO, Ezechi OC, Loto OM, Ezeobi PM: Uterine Leiomyomata in South Western Nigeria: a clinical study of presentations and management outcome. Afr Health Sci 2011, 11: 271-278.
 
[4]  Aboyeji AP, Ijaiya MA: Uterine fibroids: a ten-year clinical review in Ilorin, Nigeria. Niger J Med 2002, 11: 16-19.
 
[5]  Akinyemi BO, Adewoye BR, Fakoya TA: Uterine fibroid: a review. Niger J Med 2004, 13: 318-329.
 
[6]  Ben-Nagi, J., et al. “Endometrial implantation factors in women with submucous uterine fibroids.” Reprod.Biomed.Online. 21.5 (2010): 610-15.
 
[7]  Crum A. The Next Century- Advances in Uterine Leiomyoma. Environ Health Perspec. 1999, 108 (5).
 
[8]  Borgfeldt C, Andolf E. Transvaginal ultrasonographic findings in the uterus and the endometrium: low prevalence of leiomyoma in a random sample of women age 25-40 years. Acta Obstet Gynecol Scand. 2000; 79(3):202-207.
 
[9]  Ogunniyi SO, Fasubaa O. Uterine fibromata in Ilesha, Nigeria. Nig. Med Pract 1990; 19:93-95.
 
[10]  Sagay S, Udoeyop EU, Pam C, Karshina JA, Daru PH, Otubu JAM (1998): Laparoscopic evaluation of 1000 consecutive infertile women in Jos Nigeria. Tropical Journal of Obstetrics and Gynaecology;15(1): 30-35.
 
[11]  Vollenhoven BJ, Lawrence AS and Healey DC (1990). Uterine fibroid: a clinical review. British Journal of Obstetrics and Gynaecology 1990: 97: 285-98.
 
[12]  Ogedengbe OK (2003). Uterine Fibroids In: Contemporary obstetrics and gynaecology for developing countries. Okonofua. F and Odunsi K (Ed) Intec printers limited Ibadan. Pg 202-213.
 
[13]  Laughlin SK, Baird DD, Savitz DA, Herring AH, Hartmann KE. Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study. Obstet Gynecol. 2009;113(3):630-635
 
[14]  Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003; 188(1):100-107.
 
[15]  Merrill RM. Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit. 2008; 14: CR24-CR31.
 
[16]  Jindabanjerd, K; Taneepanichskul, S (2006). “The use of levonorgestrel - IUD in the treatment of uterine myoma in Thai women”. Journal of the Medical Association of Thailand. 89 Suppl 4: S147-51. PMID 17726816.
 
[17]  Okezie O, Ezegwui HU: Management of uterine fibroids in Enugu, Nigeria. J Obstet Gynaecol 2006, 26: 363-365.
 
[18]  Sankaran, S.; Manyonda, I. (2008). “Medical management of fibroids”. Best Practice & Research Clinical Obstetrics & Gynaecology 22 (4): 655.
 
[19]  Ozumba BC, Megafu UC, Igwegbe AO: Uterine fibroids: clinical presentation and management in a Nigerian teaching hospital. Ir Med J 1992, 85: 158-159.
 
[20]  Emembolu JO: Uterine fibromyomata: presentation and management in northern Nigeria. Int J Gynaecol Obstet 1987, 25: 413-416.
 
[21]  Legendre, G., J. L. Brun, and H. Fernandez. “[The place of myomectomy in woman of reproductive age].” J.Gynecol.Obstet.Biol.Reprod.(Paris) 40.8 (2011): 875-84.
 
[22]  Bendifallah, S., J. L. Brun, and H. Fernandez. “[Myomectomy for infertile women: the role of surgery].” J.Gynecol.Obstet.Biol.Reprod.(Paris) 40.8 (2011): 885-901.
 
[23]  Ekwere PD, Archibong EI, Bassey EE, Ekabua JE, Ekanem EI, Feyi –Waboso P (2007). Infertility among Nigerian Couples as seen in Calabar, Port Harcourt Med. J. 2: 35-40.
 
[24]  Olotu EJ, Osunwoke EA, Ugboma HA, Odu, KN. Age prevalence of uterine fibroids in south-southern Nigeria: A retrospective study. Scientific Research and Essay Vol.3 (9), pp. 457-459, September, 2008.
 
[25]  Ezugwu EC, Iyoke CA, Ezugwu FO, Ugwu G: Successful pregnancy following myomectomy for giant uterine fibroid in an infertile woman. J Reprod Infertil 2014, 15: 233-236.
 
[26]  Obed JY, Bako B, Kadas S, Usman JD, Kullima AA, Moruppa JY: The benefit of myomectomy in women aged 40 years and above: Experience in an urban teaching hospital in Nigeria. Niger Med J 2011, 52: 158-162.
 
[27]  Adesiyun AG, Ojabo A, Durosinlorun-Mohammed A: Fertility and obstetric outcome after caesarean myomectomy. J Obstet Gynaecol 2008, 28: 710-712.
 
[28]  Egwuatu VE: Fertility and fetal salvage among women with uterine leiomyomas in a Nigerian Teaching Hospital. Int J Fertil 1989, 34: 341-346.
 
[29]  Geidam AD, Lawan ZM, Chama C, Bako BG: Indications and outcome of abdominal myomectomy in University of Maiduguri Teaching Hospital: Review of ten year. Niger Med J 2011, 52: 193-197.
 
[30]  Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril.2007; 87(4):725–36.
 
[31]  Fields KR, Neinstein LS. Uterine myomas in adolescents: case reports and a review of the literature. J Pediatr Adolesc Gynecol. 1996; 9(4):195-198.
 
[32]  Okolo S. Incidence, aetiology and epidemiology of uterine fibroids. Best practice & research. Clinical obstetrics & gynaecology 2008. 22 (4): 571-588.
 
[33]  Elugwaraonu O, Okojie AIO, Okhia O, Oyadoghan GP. The Incidence of Uterine Fibroid Among Reproductive Age Women: A Five Year Review of Cases at ISTH, Irrua, Edo, Nigeria. International Journal of Basic, Applied and Innovative Research IJBAIR, 2013, 2(3): 55-60.
 
[34]  Akinyemi BO, Adewoye BR, Fakoya TA: Uterine fibroid: a review. Niger J Med 2004, 13: 318-329.
 
[35]  Omu AE, Ihejerika IJ, Tabowei G: Management of uterine fibroids at the University of Benin Teaching Hospital. Trop Doct 1984, 14: 82-85.
 
[36]  Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril. 2007; 87(4):725-36.
 
[37]  Adegbesan-Omilabu MA, Okunade KS, Gbadegesin A: Knowledge of, Perception of, and Attitude towards Uterine Fibroids among Women with Fibroids in Lagos, Nigeria. Scientifica (Cairo ) 2014, 2014: 809536.
 
[38]  Adinma, J.I.B. Uterine fibroid and fertility in Enugu. Nig. Med. J. 1999. 5: 3-5.
 
[39]  Vilos, G. A. “Uterine fibroids: relationships to reproduction.” Minerva Ginecol. 55.5 (2003): 417-23.
 
[40]  Chaker, A., et al. “[Uterine fibromyomas: fertility after myomectomy. About 41 cases].” Tunis Med. 82.12 (2004): 1075-81.
 
[41]  Connolly, G., et al. “Fertility after abdominal myomectomy.” J.Obstet.Gynaecol. 20.4 (2000): 418-20.
 
[42]  Kasum, M. “Fertility following myomectomy.” Acta Clin.Croat. 48.2 (2009): 137-43.
 
[43]  Olive, D. L., S. R. Lindheim, and E. A. Pritts. “Non-surgical management of leiomyoma: impact on fertility.” Curr.Opin.Obstet.Gynecol. 16.3 (2004): 239-43.
 
[44]  Luciano, A. A. “Myomectomy.” Clin.Obstet.Gynecol. 52.3 (2009): 362-71.
 
[45]  Kably, Ambe A., et al. “[Abdominal myomectomy and subsequent fertility].” Ginecol.Obstet.Mex. 58 (1990): 274-76.
 
[46]  Poncelet, C., et al. “[Myoma and infertility: analysis of the literature].” Gynecol.Obstet.Fertil. 29.6 (2001): 413-21.
 
[47]  Smith, D. C. and J. K. Uhlir. “Myomectomy as a reproductive procedure.” Am.J.Obstet.Gynecol. 162.6 (1990): 1476-79.
 
[48]  Veliz, V. H. and G. Rosa. “[Myomectomy to preserve fertility].” Rev.Chil.Obstet.Ginecol. 59.1 (1994): 49-52.
 
[49]  Metwally, M., Y. C. Cheong, and A. W. Horne. “Surgical treatment of fibroids for subfertility.” Cochrane.Database.Syst.Rev. 11 (2012): CD003857.